Mechanistic insight into Myc stabilization in breast cancer involving aberrant Axin1 expression

Xiaoli Zhang, Amy Farrell, Colin J. Daniel, Hugh Arnold, Charles Scanlan, Bryan J. Laraway, Mahnaz Janghorban, Lawrence Lum, Dexi Chen, Megan Troxell, Rosalie Sears

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

High expression of the oncoprotein Myc has been linked to poor outcome in human tumors. Although MYC gene amplification and translocations have been observed, this can explain Myc overexpression in only a subset of human tumors. Myc expression is in part controlled by its protein stability, which can be regulated by phosphorylation at threonine 58 (T58) and serine 62 (S62). We now report that Myc protein stability is increased in a number of breast cancer cell lines and this correlates with increased phosphorylation at S62 and decreased phosphorylation at T58. Moreover, we find this same shift in phosphorylation in primary breast cancers. The signaling cascade that controls phosphorylation at T58 and S62 is coordinated by the scaffold protein Axin1. We therefore examined Axin1 in breast cancer and report decreased AXIN1 expression and a shift in the ratio of expression of two naturally occurring AXIN1 splice variants. We demonstrate that this contributes to increased Myc protein stability, altered phosphorylation at S62 and T58, and increased oncogenic activity of Myc in breast cancer. Thus, our results reveal an important mode of Myc activation in human breast cancer and a mechanism contributing to Myc deregulation involving unique insight into inactivation of the Axin1 tumor suppressor in breast cancer.

Original languageEnglish (US)
Pages (from-to)2790-2795
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume109
Issue number8
DOIs
StatePublished - Feb 21 2012

Fingerprint

Phosphorylation
Threonine
Breast Neoplasms
Serine
Protein Stability
Neoplasms
Gene Amplification
Oncogene Proteins
Cell Line
Proteins

Keywords

  • ERK
  • Fbw7
  • GSK3β
  • PP2A
  • Ras

ASJC Scopus subject areas

  • General

Cite this

Mechanistic insight into Myc stabilization in breast cancer involving aberrant Axin1 expression. / Zhang, Xiaoli; Farrell, Amy; Daniel, Colin J.; Arnold, Hugh; Scanlan, Charles; Laraway, Bryan J.; Janghorban, Mahnaz; Lum, Lawrence; Chen, Dexi; Troxell, Megan; Sears, Rosalie.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, No. 8, 21.02.2012, p. 2790-2795.

Research output: Contribution to journalArticle

Zhang, Xiaoli ; Farrell, Amy ; Daniel, Colin J. ; Arnold, Hugh ; Scanlan, Charles ; Laraway, Bryan J. ; Janghorban, Mahnaz ; Lum, Lawrence ; Chen, Dexi ; Troxell, Megan ; Sears, Rosalie. / Mechanistic insight into Myc stabilization in breast cancer involving aberrant Axin1 expression. In: Proceedings of the National Academy of Sciences of the United States of America. 2012 ; Vol. 109, No. 8. pp. 2790-2795.
@article{1ee30e975bd54c7ea653e98c87915846,
title = "Mechanistic insight into Myc stabilization in breast cancer involving aberrant Axin1 expression",
abstract = "High expression of the oncoprotein Myc has been linked to poor outcome in human tumors. Although MYC gene amplification and translocations have been observed, this can explain Myc overexpression in only a subset of human tumors. Myc expression is in part controlled by its protein stability, which can be regulated by phosphorylation at threonine 58 (T58) and serine 62 (S62). We now report that Myc protein stability is increased in a number of breast cancer cell lines and this correlates with increased phosphorylation at S62 and decreased phosphorylation at T58. Moreover, we find this same shift in phosphorylation in primary breast cancers. The signaling cascade that controls phosphorylation at T58 and S62 is coordinated by the scaffold protein Axin1. We therefore examined Axin1 in breast cancer and report decreased AXIN1 expression and a shift in the ratio of expression of two naturally occurring AXIN1 splice variants. We demonstrate that this contributes to increased Myc protein stability, altered phosphorylation at S62 and T58, and increased oncogenic activity of Myc in breast cancer. Thus, our results reveal an important mode of Myc activation in human breast cancer and a mechanism contributing to Myc deregulation involving unique insight into inactivation of the Axin1 tumor suppressor in breast cancer.",
keywords = "ERK, Fbw7, GSK3β, PP2A, Ras",
author = "Xiaoli Zhang and Amy Farrell and Daniel, {Colin J.} and Hugh Arnold and Charles Scanlan and Laraway, {Bryan J.} and Mahnaz Janghorban and Lawrence Lum and Dexi Chen and Megan Troxell and Rosalie Sears",
year = "2012",
month = "2",
day = "21",
doi = "10.1073/pnas.1100764108",
language = "English (US)",
volume = "109",
pages = "2790--2795",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "8",

}

TY - JOUR

T1 - Mechanistic insight into Myc stabilization in breast cancer involving aberrant Axin1 expression

AU - Zhang, Xiaoli

AU - Farrell, Amy

AU - Daniel, Colin J.

AU - Arnold, Hugh

AU - Scanlan, Charles

AU - Laraway, Bryan J.

AU - Janghorban, Mahnaz

AU - Lum, Lawrence

AU - Chen, Dexi

AU - Troxell, Megan

AU - Sears, Rosalie

PY - 2012/2/21

Y1 - 2012/2/21

N2 - High expression of the oncoprotein Myc has been linked to poor outcome in human tumors. Although MYC gene amplification and translocations have been observed, this can explain Myc overexpression in only a subset of human tumors. Myc expression is in part controlled by its protein stability, which can be regulated by phosphorylation at threonine 58 (T58) and serine 62 (S62). We now report that Myc protein stability is increased in a number of breast cancer cell lines and this correlates with increased phosphorylation at S62 and decreased phosphorylation at T58. Moreover, we find this same shift in phosphorylation in primary breast cancers. The signaling cascade that controls phosphorylation at T58 and S62 is coordinated by the scaffold protein Axin1. We therefore examined Axin1 in breast cancer and report decreased AXIN1 expression and a shift in the ratio of expression of two naturally occurring AXIN1 splice variants. We demonstrate that this contributes to increased Myc protein stability, altered phosphorylation at S62 and T58, and increased oncogenic activity of Myc in breast cancer. Thus, our results reveal an important mode of Myc activation in human breast cancer and a mechanism contributing to Myc deregulation involving unique insight into inactivation of the Axin1 tumor suppressor in breast cancer.

AB - High expression of the oncoprotein Myc has been linked to poor outcome in human tumors. Although MYC gene amplification and translocations have been observed, this can explain Myc overexpression in only a subset of human tumors. Myc expression is in part controlled by its protein stability, which can be regulated by phosphorylation at threonine 58 (T58) and serine 62 (S62). We now report that Myc protein stability is increased in a number of breast cancer cell lines and this correlates with increased phosphorylation at S62 and decreased phosphorylation at T58. Moreover, we find this same shift in phosphorylation in primary breast cancers. The signaling cascade that controls phosphorylation at T58 and S62 is coordinated by the scaffold protein Axin1. We therefore examined Axin1 in breast cancer and report decreased AXIN1 expression and a shift in the ratio of expression of two naturally occurring AXIN1 splice variants. We demonstrate that this contributes to increased Myc protein stability, altered phosphorylation at S62 and T58, and increased oncogenic activity of Myc in breast cancer. Thus, our results reveal an important mode of Myc activation in human breast cancer and a mechanism contributing to Myc deregulation involving unique insight into inactivation of the Axin1 tumor suppressor in breast cancer.

KW - ERK

KW - Fbw7

KW - GSK3β

KW - PP2A

KW - Ras

UR - http://www.scopus.com/inward/record.url?scp=84863115732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863115732&partnerID=8YFLogxK

U2 - 10.1073/pnas.1100764108

DO - 10.1073/pnas.1100764108

M3 - Article

C2 - 21808024

AN - SCOPUS:84863115732

VL - 109

SP - 2790

EP - 2795

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 8

ER -